MiMedx Group, Inc.
MDXG
$6.96
-$0.21-2.93%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.34% | 8.52% | 10.93% | 15.41% | 19.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.34% | 8.52% | 10.93% | 15.41% | 19.20% |
| Cost of Revenue | 15.29% | 9.96% | 3.34% | 7.45% | 8.67% |
| Gross Profit | 3.37% | 8.23% | 12.58% | 17.14% | 21.53% |
| SG&A Expenses | 2.36% | 0.04% | -2.09% | -4.60% | -3.93% |
| Depreciation & Amortization | -11.55% | 0.13% | 1.33% | 3.12% | 5.83% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.03% | 1.83% | 1.11% | -1.12% | -0.90% |
| Operating Income | 7.11% | 59.81% | 93.27% | 330.52% | 979.07% |
| Income Before Tax | 24.05% | 87.04% | 125.60% | 560.94% | 491.83% |
| Income Tax Expenses | 142.12% | 141.55% | -4,444.13% | -49,825.86% | -17,888.66% |
| Earnings from Continuing Operations | -49.06% | -37.72% | 230.43% | 896.35% | 787.73% |
| Earnings from Discontinued Operations | 103.70% | 104.57% | 122.89% | 118.80% | -96.32% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.56% | -27.15% | 1,939.61% | 804.25% | 393.52% |
| EBIT | 7.11% | 59.81% | 93.27% | 330.52% | 979.07% |
| EBITDA | 16.36% | 61.20% | 85.12% | 262.87% | 3,052.68% |
| EPS Basic | -46.54% | -25.83% | 2,871.49% | 473.69% | 285.04% |
| Normalized Basic EPS | 2.24% | 54.52% | 90.48% | 475.68% | 472.39% |
| EPS Diluted | -44.86% | -23.25% | 4,401.45% | 472.57% | 274.37% |
| Normalized Diluted EPS | 20.70% | 95.35% | 110.31% | 560.74% | 411.76% |
| Average Basic Shares Outstanding | 18.20% | 26.13% | 21.89% | 15.94% | 9.77% |
| Average Diluted Shares Outstanding | 0.24% | 6.69% | 13.63% | 22.39% | 31.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |